14-Oct-2014 - Aesica has turned its back on sterile injectables manufacturing and, in an exclusive interview, told Outsourcing-Pharma.com there is now limited steriles capability in the UK following the exit of other key players.
02-Oct-2014 - Catalent has urged industry and academia to share knowledge about delivery technologies to help improve drug efficacy as it signs a deal to develop ADHD treatments for Cingulate.
02-Oct-2014 - Flexible inkjet printing and personalized medicine will grow the market for orodispersible delivery technologies according to experts at a conference in Germany this week.
25-Sep-2014 - Acorda has gained a pulmonary delivery technology and a GMP manufacturing site in Massachusetts along with a Parkinson’s disease candidate in its $525m (€410m) acquisition of Civitas.
22-Sep-2014 - Telormedix has been granted a European patent for increasing the solubility of its lead bladder cancer toll-like receptors (TLR) treatment Vesimune.
17-Sep-2014 - On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a look at the pharma inventions Scotland gave the world.
16-Sep-2014 - Almac’s subsidiary Galen has licensed UK sales and marketing rights to an emergency pain drug nicknamed the “green whistle” from Australian firm Medical Developments International (MVP).
15-Sep-2014 - Unilife has invested in manufacturing capacity for its drug delivery devices ahead of schedule to support the accelerated commercial launch date of its customers' products.
15-Sep-2014 - Researchers from the National University of Singapore (NUS) have developed a microneedle patch that can deliver lidocaine in what they say is a “faster, more effective and painless” way.
11-Sep-2014 - Indian drugmaker Cipla has bought two manufacturing facilities from its contractor Okasa Pharma.
10-Sep-2014 - The Natoli Engineering Company has opened an pharmaceutical research institute to look for answers to enduring formulation problems in solid oral dosage.
09-Sep-2014 - Food scientists may have hit on a novel delivery method for HIV antiretrovirals: a vaginal suppository made with seaweed.
04-Sep-2014 - Meda has sold a New Jersey facility dedicated to its intra-urethral erectile dysfunction drug Muse as part of a strategic review of its manufacturing network.
03-Sep-2014 - Canadian drugmaker Intellipharmaceutics has developed a kill-switch formulation it says will prevent drug misuse and accidental overdoses.
02-Sep-2014 - Pharma firms must provide imaginative solid dosage alternatives to tablets and capsules, says research claiming more than half of patients have problems swallowing traditional pills.
29-Aug-2014 - BTG has received approval from the China FDA for a liver cancer treatment which uses its hydrogel product DC Beads.
29-Aug-2014 - A candidate Ebola vaccine that uses Immunovaccine's formulation technology has stopped cynomolgus monkeys from catching the disease in a preclinical study.
21-Aug-2014 - US FDA approval of the inhaled corticosteroid (ICS) asthma drug Arnuity will help offset declining sales of the off-patent bestseller Advair, says GlaxoSmithKline.
19-Aug-2014 - For the first time ever, the US FDA has approved a needle-free injection system to deliver the seasonal flu vaccine.
12-Aug-2014 - Pricks are a problem for the drug industry according to Prometheon Pharma, which has launched a crowdfunding campaign to help it develop a needle-free alternative delivery tech.
12-Aug-2014 - Chiasma says a scale-up manufacturing agreement with Capsugel will be unaffected despite Roche pulling out of a commercialisation contract for its oral peptide drug octreotide acetate.
11-Aug-2014 - Mannkind has partnered Sanofi for the marketing and commercialisation of its inhaled insulin drug Afrezza, recently approved by the US FDA.
06-Aug-2014 - Pancreatic cancer is notoriously difficult to treat. One problem is drug delivery, because pancreatic cells can cluster in a nest of scar-like tissue.
06-Aug-2014 - Actavis says it is excited to partner with AstraZeneca over its long-acting muscarinic antagonist/beta-agonist (LAMA/LABA) fixed dose combination respiratory drug following the latter’s acquisition of Almirall.
05-Aug-2014 - Roche has renewed its interest in gene silencing drugs, paying $250m (€187m) for Santaris Pharma including its ‘antisense’ Locked Nucleic Acid (LNA) platform.
The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert...
dispatches from technopharm
Flexible inkjet printing and personalized medicine will grow the market for orodispersible delivery technologies according to experts...
Pre CPhI Special
The world is getting larger, at least it is in terms of the pharmaceutical industry, according to...
Pre CPhI Special
Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to...
The Pharma industry has responded to the Ebola crisis in West Africa with developmental vaccines and aid...
The US National Institutes of Health (NIH) is collecting photos of pills and tablet in a database...